540694 — ANG Lifesciences India Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for ANG Lifesciences India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	43.7	36	38.6	183	185
Net Total Accounts Receivable
Net Total Receivables	491	533	820	1,021	1,123
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	600	727	1,159	1,928	1,869
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	208	209	239	926	881
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	809	941	1,437	2,910	2,797
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	424	509	916	1,663	1,623
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	521	595	1,021	2,073	1,935
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	288	346	416	838	862
Total Liabilities & Shareholders' Equity	809	941	1,437	2,910	2,797
Total Common Shares Outstanding